Maryam Poursadeghfard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maryam Poursadeghfard has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Sina Karamimagham
Specialty in neonatology, Shiraz University of Medical Sciences, Shiraz, Iran
3 shared publicationsHoda Kamali
Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran
2 shared publicationsAbdorreza Naser Moghadasi
Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Afshin Borhani-Haghighi
Shiraz University of Medical Sciences
1 shared publication Aida Aramesh
School of medicine, Kazeroon Branch, Islamic Azad University, Kazeroon, Iran
1 shared publicationAli Reza Nikseresht
Associate Professor of Neurology, Clinical Neurology Research Center, Department of Neurology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication
Latest Publications
- Open Access
- 13 August 2025
- Published by Korean Acupuncture and Moxibustion Medicine Society in Journal of Acupuncture Research
- Vol. 42, 344-354
A Comparative Study of Acupuncture and Oral Amantadine in Relieving Fatigue in Patients with Multiple Sclerosis: A Randomized Clinical Trial
Mohammadjavad Hadianfard, Maryam Poursadeghfard, Nasim Fazeli. Journal of Acupuncture Research 2025;42:344-54. https://doi.org/10.13045/jar.25.0009
- 13 August 2025
- Published by Korean Acupuncture and Moxibustion Medicine Society in Journal of Acupuncture Research
- Vol. 42, 344-354
Open AccessA Comparative Study of Acupuncture and Oral Amantadine in Relieving Fatigue in Patients with Multiple Sclerosis: A Randomized Clinical Trial
Mohammadjavad Hadianfard, Maryam Poursadeghfard, Nasim Fazeli. Journal of Acupuncture Research 2025;42:344-54. https://doi.org/10.13045/jar.25.0009
- 9 August 2024
- Published by SAGE Publications in Telemedicine and e-Health
- Vol. 30 (8) , e2214-e2231
Comparison of the Clinical Effectiveness of Telerehabilitation with Traditional Rehabilitation Methods in Multiple Sclerosis Patients: A Systematic Review
Background: The rehabilitation process for multiple sclerosis (MS) patients is long and complex, which can lead to reduced rehabilitation outcomes and reduced quality improvement. Thus, there is a need to use new methods to boost traditional rehabilitation. Innovations such as telerehabilitation can be helpful to remove the obstacles to treatment, but evidence for their effectiveness is limited. The objective of this work was to compare the clinical effectiveness of telerehabilitation with traditional interventions in MS patients. Methods: Seven bibliographic databases (PubMed, Cochran Library, Scopus, Science Direct, Web of Science, Embase, and ProQuest) were used in this research. The initial search resulted in the extraction of 8,239 articles; after the review of the title, abstract, and full text, 11 articles were selected. In addition, backward reference list checking of the selected studies was conducted. Studies that were related to our objectives were included. Quality assessment was performed using the CONSORT checklist. Then, data extraction was done using the form set by the researcher in Word 2016 software. Results: Overall, telerehabilitation achieved more positive effects compared to traditional rehabilitation on physical ( n = 6), cognitive ( n = 3), cognitive, and physical outcomes ( n = 2), respectively. Synchronous telerehabilitation was more effective than other modalities ( n = 8). In four studies, virtual reality-based telerehabilitation was used. Also, telerehabilitation in home offered better clinical outcomes compared to rehabilitation center ( n = 9). Conclusions: This review provides evidence for the potential effectiveness of telerehabilitation for the improvement of clinical outcomes in MS patients. However, more robust randomized controlled trials are needed to confirm the observed positive effects.
- 9 August 2024
- Published by SAGE Publications in Telemedicine and e-Health
- Vol. 30 (8) , e2214-e2231
Comparison of the Clinical Effectiveness of Telerehabilitation with Traditional Rehabilitation Methods in Multiple Sclerosis Patients: A Systematic Review
Background: The rehabilitation process for multiple sclerosis (MS) patients is long and complex, which can lead to reduced rehabilitation outcomes and reduced quality improvement. Thus, there is a need to use new methods to boost traditional rehabilitation. Innovations such as telerehabilitation can be helpful to remove the obstacles to treatment, but evidence for their effectiveness is limited. The objective of this work was to compare the clinical effectiveness of telerehabilitation with traditional interventions in MS patients. Methods: Seven bibliographic databases (PubMed, Cochran Library, Scopus, Science Direct, Web of Science, Embase, and ProQuest) were used in this research. The initial search resulted in the extraction of 8,239 articles; after the review of the title, abstract, and full text, 11 articles were selected. In addition, backward reference list checking of the selected studies was conducted. Studies that were related to our objectives were included. Quality assessment was performed using the CONSORT checklist. Then, data extraction was done using the form set by the researcher in Word 2016 software. Results: Overall, telerehabilitation achieved more positive effects compared to traditional rehabilitation on physical ( n = 6), cognitive ( n = 3), cognitive, and physical outcomes ( n = 2), respectively. Synchronous telerehabilitation was more effective than other modalities ( n = 8). In four studies, virtual reality-based telerehabilitation was used. Also, telerehabilitation in home offered better clinical outcomes compared to rehabilitation center ( n = 9). Conclusions: This review provides evidence for the potential effectiveness of telerehabilitation for the improvement of clinical outcomes in MS patients. However, more robust randomized controlled trials are needed to confirm the observed positive effects.
- 4 February 2023
- Published by Springer Nature in Iranian Journal of Science
- Vol. 47 (2) , 501-513
Optimal Approximation of Fractional Order Brain Tumor Model Using Generalized Laguerre Polynomials
A brain tumor occurs when abnormal cells form within the brain. Glioblastoma (GB) is an aggressive and fast-growing type of brain tumor that invades brain tissue or spinal cord. GB evolves from astrocytic glial cells in the central nervous system. GB can occur at almost any age, but the occurrence increases with advancing age in older adults. Its symptoms may include nausea, vomiting, headaches, or even seizures. GB, formerly known as glioblastoma multiforme, currently has no cure with a high rate of resistance to therapy in clinical treatment. However, treatments can slow tumor progression or alleviate the signs and symptoms. In this paper, a fractional order brain tumor model was considered. The optimal solution of the model was obtained using an optimization method based on operational matrices. The solution to the problem under study was expanded in terms of generalized Laguerre polynomials (GLPs). The study problem was shifted to a system of nonlinear algebraic equations by the use of Lagrange multipliers combined with operational matrices based on GLPs. The analysis of convergence was discussed. In the end, some numerical examples were presented to justify theoretical statements along with the patterns of biological behavior.
- 4 February 2023
- Published by Springer Nature in Iranian Journal of Science
- Vol. 47 (2) , 501-513
Optimal Approximation of Fractional Order Brain Tumor Model Using Generalized Laguerre Polynomials
A brain tumor occurs when abnormal cells form within the brain. Glioblastoma (GB) is an aggressive and fast-growing type of brain tumor that invades brain tissue or spinal cord. GB evolves from astrocytic glial cells in the central nervous system. GB can occur at almost any age, but the occurrence increases with advancing age in older adults. Its symptoms may include nausea, vomiting, headaches, or even seizures. GB, formerly known as glioblastoma multiforme, currently has no cure with a high rate of resistance to therapy in clinical treatment. However, treatments can slow tumor progression or alleviate the signs and symptoms. In this paper, a fractional order brain tumor model was considered. The optimal solution of the model was obtained using an optimization method based on operational matrices. The solution to the problem under study was expanded in terms of generalized Laguerre polynomials (GLPs). The study problem was shifted to a system of nonlinear algebraic equations by the use of Lagrange multipliers combined with operational matrices based on GLPs. The analysis of convergence was discussed. In the end, some numerical examples were presented to justify theoretical statements along with the patterns of biological behavior.
- 1 June 2020
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 41, 102021
Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod
- 1 June 2020
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 41, 102021
Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod
- Open Access
- 1 January 2020
- Vol. 11 (2) , 223-226
Concurrence of multiple sclerosis and primary biliary cholangitis: Report of 3 cases
- 1 January 2020
- Vol. 11 (2) , 223-226
Open AccessConcurrence of multiple sclerosis and primary biliary cholangitis: Report of 3 cases
- 1 January 2020
- Published by Negah Scientific Publisher in Caspian Journal of Neurological Sciences
- Vol. 6 (1) , 9-15
Predictors and Conversion Rate of Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis: A Follow-up Study in Patients Living in the Southern Part of Iran
Background: Clinical course of Clinically Isolated Syndrome (CIS) is variable, and identifying patients who will eventually develop Multiple Sclerosis (MS) is essential. Objectives: To assess the conversion rate of CIS to Clinically Definite Multiple Sclerosis (CDMS) and its predictors in southern Iran. Materials & Methods: A total of 143 CIS patients registered to Fars Multiple Sclerosis Society (FMSS) were enrolled in the study from 2006 until 2012, and all of them were followed for 5 years. Also, their demographic and MRI data were recorded. The obtained data were analyzed by univariate and multivariable Cox regression models in SPSS v. 17. P<0.05 was considered statistically significant. Results: About 26.6% of patients progressed to MS after a mean duration of 3.4±1.1 years. The conversion rate was 27.6% in patients presented with optic neuritis, and 25.6% in patients presented with spinal cord problems. Although it was not statistically significant (P=0.23), the mean age of the patients who converted to MS was lower at the onset of the presentation (27.6 vs. 29.4 years). In patients who had 3 or more MRI lesions, the conversion rate was 49.2%; however, it was only 9.8% in subjects who had fewer than 3 lesions (OR=8.95, 95% CI=3.69–21.7, P <0.001). Women had higher conversion rate though it was not statistically significant (OR=2.09, 95% CI=0.57–7.64, P=0.26). Conclusion: Our results supported this supposition that the number of MRI lesions at baseline can be used as a predictor of CIS conversion to MS.
- 1 January 2020
- Published by Negah Scientific Publisher in Caspian Journal of Neurological Sciences
- Vol. 6 (1) , 9-15
Predictors and Conversion Rate of Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis: A Follow-up Study in Patients Living in the Southern Part of Iran
Background: Clinical course of Clinically Isolated Syndrome (CIS) is variable, and identifying patients who will eventually develop Multiple Sclerosis (MS) is essential. Objectives: To assess the conversion rate of CIS to Clinically Definite Multiple Sclerosis (CDMS) and its predictors in southern Iran. Materials & Methods: A total of 143 CIS patients registered to Fars Multiple Sclerosis Society (FMSS) were enrolled in the study from 2006 until 2012, and all of them were followed for 5 years. Also, their demographic and MRI data were recorded. The obtained data were analyzed by univariate and multivariable Cox regression models in SPSS v. 17. P<0.05 was considered statistically significant. Results: About 26.6% of patients progressed to MS after a mean duration of 3.4±1.1 years. The conversion rate was 27.6% in patients presented with optic neuritis, and 25.6% in patients presented with spinal cord problems. Although it was not statistically significant (P=0.23), the mean age of the patients who converted to MS was lower at the onset of the presentation (27.6 vs. 29.4 years). In patients who had 3 or more MRI lesions, the conversion rate was 49.2%; however, it was only 9.8% in subjects who had fewer than 3 lesions (OR=8.95, 95% CI=3.69–21.7, P <0.001). Women had higher conversion rate though it was not statistically significant (OR=2.09, 95% CI=0.57–7.64, P=0.26). Conclusion: Our results supported this supposition that the number of MRI lesions at baseline can be used as a predictor of CIS conversion to MS.
- 1 January 2020
- Published by Wolters Kluwer Health in Gastroenterology Nursing
- Vol. 43 (2) , 196-198
PARKINSONʼS DISEASE ACCOMPANIED BY PRIMARY BILIARY CIRRHOSIS
- 1 January 2020
- Published by Wolters Kluwer Health in Gastroenterology Nursing
- Vol. 43 (2) , 196-198
PARKINSONʼS DISEASE ACCOMPANIED BY PRIMARY BILIARY CIRRHOSIS
- Open Access
- 31 December 2019
- Published by Maad Rayan Publishing Company in International Journal of Basic Science in Medicine
- Vol. 4 (4) , 128-130
Simultaneous Presence of Acetylcholine Receptor and Muscle Specific Tyrosine Kinase Antibodies in Myasthenia Gravis
Myasthenia gravis (MG) is known as an autoimmune disorder which affects transmission in neuromuscular junction. The serologic tests used for diagnosis include acetylcholine receptor and muscle specific receptor tyrosine kinase antibodies. Studies often have reported that patients with formal antibody are negative for the latter one. However, very limited studies have reported positive anti-muscle specific receptor tyrosine kinase antibody in a small percentage of patients with acetylcholine receptor antibody. Here, we reported a young woman who was diagnosed with MG and had a rapid and progressive course of the disease. She was seropositive for both acetylcholine receptor and muscle-specific receptor tyrosine kinase antibodies simultaneously. However, she discharged from the hospital with good condition after treatment.
- 31 December 2019
- Published by Maad Rayan Publishing Company in International Journal of Basic Science in Medicine
- Vol. 4 (4) , 128-130
Open AccessSimultaneous Presence of Acetylcholine Receptor and Muscle Specific Tyrosine Kinase Antibodies in Myasthenia Gravis
Myasthenia gravis (MG) is known as an autoimmune disorder which affects transmission in neuromuscular junction. The serologic tests used for diagnosis include acetylcholine receptor and muscle specific receptor tyrosine kinase antibodies. Studies often have reported that patients with formal antibody are negative for the latter one. However, very limited studies have reported positive anti-muscle specific receptor tyrosine kinase antibody in a small percentage of patients with acetylcholine receptor antibody. Here, we reported a young woman who was diagnosed with MG and had a rapid and progressive course of the disease. She was seropositive for both acetylcholine receptor and muscle-specific receptor tyrosine kinase antibodies simultaneously. However, she discharged from the hospital with good condition after treatment.